Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Reset all filters
01 2Biophore India Pharmaceuticals Pvt Ltd
02 1Transo-Pharm USA LLC
03 1NanoAlvand
04 1Ahk Tech
05 1Aspen Bio
06 1Axitec
07 2Cilag AG
08 1Guangzhou Henovcom Biosciences
09 1Hubei Biocause Heilen Pharmaceutical Co., Ltd
10 1Lipomed AG
11 2MSN Laboratories
12 1Mac-Chem Products (India) Pvt.Ltd
13 1Morepen Laboratories
14 1Reliable Biopharmaceutical Corporation
15 2ScinoPharm Taiwan Ltd
16 1Sichuan Huiyu Pharmaceutical
17 2Sionc Pharmaceuticals
18 1Synbias Pharma
19 1Zhejiang Hisun Chemical Co., Ltd.
20 1Zhejiang Hisun Pharmaceutical
Reset all filters
01 7China
02 9India
03 1Iran
04 4Switzerland
05 2Taiwan
06 2U.S.A
Reset all filters
01 10Active
02 3Inactive
03 12Blank
01 6Valid
02 1Withdrawn by Holder
03 18Blank
Reset all filters
01 1305MF10067
02 24Blank
Reset all filters
01 1WC-0349
02 24Blank
Reset all filters
01 25Blank
Reset all filters
01 112502-4912
02 112502-5406
03 154893-0115
04 154893-0117
05 158623-0037
06 159605-3006
07 265129-1260
08 176055-0051
09 176055-0052
10 15Blank
01 25Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-09
Pay. Date : 2021-09-28
DMF Number : 36221
Submission : 2021-08-30
Status : Active
Type : II
Certificate Number : CEP 2022-078 - Rev 00
Issue Date : 2024-06-03
Type : Chemical
Substance Number : 2174
Status : Valid
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36222
Submission : 2021-08-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-18
Pay. Date : 2012-12-18
DMF Number : 16205
Submission : 2002-10-22
Status : Active
Type : II
Certificate Number : R0-CEP 2012-132 - Rev 00
Issue Date : 2014-10-29
Type : Chemical
Substance Number : 2174
Status : Withdrawn by Holder
NDC Package Code : 58623-0037
Start Marketing Date : 2004-04-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-10-15
Pay. Date : 2018-06-27
DMF Number : 13006
Submission : 1998-05-28
Status : Active
Type : II
NDC Package Code : 59605-3006
Start Marketing Date : 1998-05-28
End Marketing Date : 2027-05-11
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31505
Submission : 2017-05-05
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-03-08
Pay. Date : 2015-08-13
DMF Number : 24510
Submission : 2010-12-30
Status : Active
Type : II
Certificate Number : CEP 2016-315 - Rev 01
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 2174
Status : Valid
NDC Package Code : 65129-1260
Start Marketing Date : 2010-05-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18072
Submission : 2005-01-31
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23228
Submission : 2009-10-16
Status : Inactive
Type : II
70
PharmaCompass offers a list of Cladribine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cladribine manufacturer or Cladribine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cladribine manufacturer or Cladribine supplier.
PharmaCompass also assists you with knowing the Cladribine API Price utilized in the formulation of products. Cladribine API Price is not always fixed or binding as the Cladribine Price is obtained through a variety of data sources. The Cladribine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Leustatin, 2-chlorodeoxyadenosine, Cladribine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leustatin, 2-chlorodeoxyadenosine, Cladribine, including repackagers and relabelers. The FDA regulates Leustatin, 2-chlorodeoxyadenosine, Cladribine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leustatin, 2-chlorodeoxyadenosine, Cladribine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Leustatin, 2-chlorodeoxyadenosine, Cladribine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Leustatin, 2-chlorodeoxyadenosine, Cladribine supplier is an individual or a company that provides Leustatin, 2-chlorodeoxyadenosine, Cladribine active pharmaceutical ingredient (API) or Leustatin, 2-chlorodeoxyadenosine, Cladribine finished formulations upon request. The Leustatin, 2-chlorodeoxyadenosine, Cladribine suppliers may include Leustatin, 2-chlorodeoxyadenosine, Cladribine API manufacturers, exporters, distributors and traders.
click here to find a list of Leustatin, 2-chlorodeoxyadenosine, Cladribine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 20 companies offering Leustatin, 2-chlorodeoxyadenosine, Cladribine
Get in contact with the supplier of your choice: